Physician profile
Grainger Steele Lanneau
NPI 1801983275
$1,929.03
in general payments reported to CMS, 2019-2025
11 companies · $982 in 2025
The $982 reported for 2025 was more than what a typical Gynecologic Oncology provider received nationally (typical 2025 total: $305).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $194 · 2020: $19.87 · 2021: $150 · 2022: $411 · 2023: $102 · 2024: $71.44 · 2025: $982.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $793 · Travel and Lodging: $362.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $792.79 |
| Travel and Lodging | $362.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $917.82 | 2019-2025 | |
| Glaxosmithkline, LLC. | $248.38 | 2022 | |
| Merck Sharp & Dohme LLC | $241.53 | 2019-2024 | Keytruda, Lynparza |
| Verastem, INC. | $138.33 | 2025 | Avmapki Fakzynja Co-Pack |
| Astrazeneca Pharmaceuticals LP | $117.11 | 2021 | |
| Eisai INC. | $101.60 | 2023 | |
| Caris Mpi, INC. | $66.36 | 2025 | Mi Cancer Seek |
| Medtronic, INC. | $38.77 | 2022 | |
| Myriad Genetic Laboratories, INC. | $33.02 | 2021 | |
| Abbvie INC. | $26.11 | 2025 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Grainger Lanneau listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.